Advanced

Taming killer cells may halt diabetes progression

Colucci, Francesco and Cilio, Corrado LU (2010) In Nature Immunology 11(2). p.111-112
Abstract
Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nature Immunology
volume
11
issue
2
pages
111 - 112
publisher
Nature Publishing Group
external identifiers
  • wos:000273730200006
  • scopus:75649151690
ISSN
1529-2908
DOI
10.1038/ni0210-111
language
English
LU publication?
yes
id
7e20105b-8813-488c-9381-6c59c459c5e1 (old id 1547226)
date added to LUP
2010-02-24 10:32:57
date last changed
2018-05-29 09:41:46
@misc{7e20105b-8813-488c-9381-6c59c459c5e1,
  abstract     = {Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.},
  author       = {Colucci, Francesco and Cilio, Corrado},
  issn         = {1529-2908},
  language     = {eng},
  number       = {2},
  pages        = {111--112},
  publisher    = {Nature Publishing Group},
  series       = {Nature Immunology},
  title        = {Taming killer cells may halt diabetes progression},
  url          = {http://dx.doi.org/10.1038/ni0210-111},
  volume       = {11},
  year         = {2010},
}